Physician

Michael Alan Kaplan, M.D.

According to 2025 Medicare claims, Michael Kaplan, M.D. (NPI: 1750443289) practices otolaryngology in the Houston-Pasadena-The Woodlands, TX market, with the plurality of this provider's patient population coming from Harris, TX. This provider's primary affiliated billing organization is MEDICAL CENTER EAR, NOSE AND THROAT ASSOCIATES OF HOUSTON, PLLC (NPI: 1124011465; TIN: 741926954) and primary practice location at 77098-5296. Kaplan is affiliated with the Honest MSSP of Michigan LLC (ACO ID: A5616), participating under the MSSP model.

Kaplan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 263 traditional Medicare patients, billed 5,596 HCPCS/CPT codes, and received $3,092,571 in Medicare payments. The top billing code was 31298 (Dilation of sphenoid and frontal nasal sinus using an endoscope). Part D data shows 1,261 prescription claims across 369 beneficiaries totaling $20,622 in drug costs, led by Xhance (Fluticasone Propionate). 2015 DME data shows 13 claims. Open Payments data shows 19 records totaling $766. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $835,516 to $3,092,571. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $33,053 and ending at $20,622. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	424	4,022	$835,516
2016	449	3,903	$951,262
2017	429	4,303	$830,254
2018	436	4,749	$1,630,452
2019	407	5,045	$1,446,623
2020	293	4,084	$1,334,712
2021	266	3,643	$1,588,874
2022	255	3,776	$2,045,761
2023	217	4,147	$2,016,191
2024	263	5,596	$3,092,571

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	190	653	$33,053
2016	215	705	$21,364
2017	211	688	$20,684
2018	282	987	$21,320
2019	307	1,109	$23,335
2020	237	910	$24,643
2021	250	977	$18,073
2022	287	1,089	$11,685
2023	299	1,069	$25,084
2024	369	1,261	$20,622

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	13	$2,414
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
31298	Dilation of sphenoid and frontal nasal sinus using an endoscope	173	174	$3,904
31295	Dilation of nasal sinus using an endoscope	178	179	$1,838
30140	Removal of nasal air passage under lining tissue	178	178	$191
77011	Ct guidance for needle or tube localization	177	178	$187
61782	Computer-assisted procedure outside membrane covering brain	176	177	$150

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xhance	Fluticasone Propionate	15	405	$9,630
Ipratropium Bromide	Ipratropium Bromide	94	2,290	$2,331
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	249	551	$1,001
Amoxicillin	Amoxicillin	243	1,715	$647
Prednisone	Prednisone	186	1,357	$342

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	19	$766	Stryker Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Alan Kaplan, M.D.?

Tedicare shows public-source Medicare data for Michael Alan Kaplan, M.D. (NPI 1750443289), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Alan Kaplan, M.D. have ACO affiliation data?

Michael Alan Kaplan, M.D. is shown with ACO affiliation data for Honest MSSP of Michigan LLC (MSSP, ACO ID A5616).

What billing organization is linked to Michael Alan Kaplan, M.D.?

Michael Alan Kaplan, M.D. is linked to MEDICAL CENTER EAR, NOSE AND THROAT ASSOCIATES OF HOUSTON, PLLC (billing NPI 1124011465) in the available physician profile data.

Does Michael Alan Kaplan, M.D. have Open Payments data?

Michael Alan Kaplan, M.D. has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.